Crossmark

Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases

Crossref DOI link: https://doi.org/10.1016/j.gastre.2024.04.045

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gutiérrez-Rios, Laura

Vayreda, Eva

Calafat, Margalida

Cañete, Fiorella

Domènech, Eugeni

Mañosa, Míriam
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01

stm-asf valid from 2024-10-01
More Information

This article is maintained by: Elsevier

Article Title: Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2024.04.045

Content Type: simple-article

Copyright: © 2023 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.